SCHEMBL22798698

SCHEMBL22798698

CCCC(Cl)c1ccc2cc(Br)ccc2c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2A6 P11509 1/20 0.39
KMT2A Q03164 2/20 0.37
KDM4E B2RXH2 1/20 0.37
MEN1 O00255 1/20 0.37
ALDH1A1 P00352 1/20 0.37
MAPT P10636 1/20 0.37
LMNA P02545 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
KDM1A O60341 1/20 0.32
HRH3 Q9Y5N1 1/20 0.32
CYP3A4 P08684 2/20 0.32
CYP2D6 P10635 2/20 0.32
SLC6A2 P23975 2/20 0.32
SLC6A4 P31645 2/20 0.32
SLC6A3 Q01959 2/20 0.32
KCNH2 Q12809 2/20 0.32
NCEH1 Q6PIU2 1/20 0.32
AKR1C3 P42330 1/20 0.31
AKR1C2 P52895 1/20 0.31
UGT2B7 P16662 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6683976 0.81 PYCR1 (0.38) CYP2A6KMT2AMEN1ALDH1A1L3MBTL1
SCHEMBL15352147 0.79 HDAC1 (0.41) CYP2A6KMT2AKDM4EMEN1ALDH1A1
SCHEMBL10520837 0.79 IDO1 (0.39) ALDH1A1L3MBTL1CYP3A4CYP2D6SLC6A2
SCHEMBL28771553 0.75 BDKRB2 (0.39) CYP3A4CYP2D6SLC6A2SLC6A4SLC6A3
SCHEMBL27361485 0.72 UGT2B7 (0.46) CYP2A6KMT2AMEN1LMNACYP3A4
SCHEMBL13849487 0.71 LMNA (0.44) CYP2A6KMT2AKDM4EMEN1ALDH1A1
SCHEMBL2627116 0.71 CYP2A6 (0.56) CYP2A6KMT2AKDM4EMEN1ALDH1A1
SCHEMBL27647959 0.71 CYP1A2 (0.37) KDM4EALDH1A1LMNAL3MBTL1CYP3A4
SCHEMBL11484393 0.71 SLC6A2 (0.47) ALDH1A1LMNASLC6A2SLC6A4SLC6A3
SCHEMBL27558953 0.70 CYP2A6 (0.48) CYP2A6KMT2AKDM4EMEN1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3753932-A1 SUBSTITUTED BICYCLIC DERIVATIVES HAVING MULTIMODAL ACTIVITY AGAINST PAIN ESTEVE PHARMACEUTICALS, S.A. (ES) 2020-12-23 EP disclosed